Notice2024-17219
Meeting of the Advisory Committee on Breast Cancer in Young Women
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
August 5, 2024
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
In accordance with the Federal Advisory Committee Act, the Centers for Disease Control and Prevention (CDC) announces the following meeting of the Advisory Committee on Breast Cancer in Young Women (ACBCYW). This meeting is open to the public, limited only by conference room space and web Conference lines (40 conference room and 60 web conference participant spaces available). Online registration is required.
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 150 (Monday, August 5, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 150 (Monday, August 5, 2024)]
[Notices]
[Page 63433]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-17219]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Meeting of the Advisory Committee on Breast Cancer in Young Women
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the
Centers for Disease Control and Prevention (CDC) announces the
following meeting of the Advisory Committee on Breast Cancer in Young
Women (ACBCYW). This meeting is open to the public, limited only by
conference room space and web Conference lines (40 conference room and
60 web conference participant spaces available). Online registration is
required.
DATES: The meeting will be held on September 13, 2024, from 8:30 a.m.
to 4 p.m., EDT.
ADDRESSES: 4770 Buford Highway, Atlanta, Georgia 30341, Building 106,
Room 1B. All ACBCYW Meeting participants must register for the meeting
online at least 5 business days in advance at <a href="https://www.cdc.gov/breast-cancer/php/advisory-committee/index.html">https://www.cdc.gov/breast-cancer/php/advisory-committee/index.html</a>. Please complete all
the required fields and submit your registration no later than
September 6, 2024. Registered participants will receive access
instructions before the meeting. All visitors are required to present a
valid form of picture identification issued by a state, federal or
international government. As required by the Federal Property
Management Regulations, all persons entering in or on Federal
controlled property and their packages, briefcases, and other
containers in their immediate possession are subject to being x-rayed
and inspected. Federal law prohibits the knowing possession or the
causing to be present of firearms, explosives and other dangerous
weapons and illegal substances. Time will be available for public
comment. The public is welcome to submit written comments in advance of
the meeting. Comments should be submitted in writing by email to
<a href="/cdn-cgi/l/email-protection#82e3e1e0e1fbf5c2e1e6e1ace5edf4"><span class="__cf_email__" data-cfemail="9afbf9f8f9e3eddaf9fef9b4fdf5ec">[email protected]</span></a>. The deadline for receipt is September 10, 2024.
FOR FURTHER INFORMATION CONTACT: Kimberly E. Smith, M.B.A., M.H.A.,
Designated Federal Officer, Advisory Committee on Breast Cancer in
Young Women, National Center for Chronic Disease Prevention and Health
Promotion, Centers for Disease Control and Prevention, 4770 Buford
Highway NE, Mailstop S107-4, Atlanta, Georgia 30341. Telephone: (404)
498-0073; Fax: (770) 488-4760; Email: <a href="/cdn-cgi/l/email-protection#80e1e3e2e3f9f7c0e3e4e3aee7eff6"><span class="__cf_email__" data-cfemail="0f6e6c6d6c76784f6c6b6c21686079">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION:
Purpose: The Advisory Committee provides advice and guidance to the
Secretary, HHS; the Assistant Secretary for Health; and the Director,
CDC, regarding the formative research, development, implementation, and
evaluation of evidence-based activities designed to prevent breast
cancer (particularly among those at heightened risk) and promote the
early detection and support of young women who develop the disease. The
advice provided by the Advisory Committee will assist in ensuring
scientific quality, timeliness, utility, and dissemination of credible
appropriate messages and resource materials.
Matters to be Considered: The agenda will include discussions on
current topics related to breast cancer in young women. These will
include Mental/Behavioral Health, Sexual Health, Genetics and Genomics,
and Provider Engagement. Agenda items are subject to change as
priorities dictate.
The Director, Office of Strategic Business Initiatives, Office of
the Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-17219 Filed 8-2-24; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on August 5, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.